They help control your appetite, slow down stomach emptying so you feel fuller longer, and improve how your body uses sugar
Patients with a BMI of 27 or higher and weight-related health issues are typically good candidates for Ozempic
While this metabolic effect supports weight management, the primary driver of GLP-1mediated weight loss is reduced calorie intake rather than a substantial increase in energy expenditure
Sources: FDA Drug Safety Communication, Jan 13, 2026 FDA prescribing labels: Ozempic, Wegovy, Mounjaro, Zepbound EMA / PRAC statement on NAION, June 6, 2025 UK MHRA Drug Safety Update on semaglutide & NAION Endocrine Society of India Clinical Practice Guidelines for Obesity, 2025 Disclaimer: This content is for educational purposes only and is not medical advice, diagnosis, or treatment
One of those assigned to work on GLP-1 at Novo Nordisk was Lotte Bjerre Knudsen (figure 37), a young researcher hired by the company in 1989 straight after she completed her chemistry training at the Technical University of Denmark
Preventing Disease "Lose money fast with Dr